All Publications
Glendon G, Frost CJ, Andrulis IL, Hanna D, John EM, Mulhall C, Phipps AI, Thompson A, Venne V, Ritvo P. A qualitative study evaluating parental attitudes towards the creation of a female youth cohort (LEGACY) in the Breast Cancer Family Registry. Psychooncology 2010;19(1):93-101.
Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, Gómez García EB, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J; CMBA. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modiferis of BRCA1/BRCA2 (CIMBA). Br J Cancer 2009;101(12):2048-54.
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Jan Lubinski J, on behalf of CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer5: kConFab, UCI, MAYO, MBCSG, ModSqad, NCI, NICCC, OCGN, OUH, PBCS, SMC, SWE-BRCA, UPENN, IHCC, CNIO, DKFZ, HEBON, EMBRACE, FCCC, GEMO, BCFR, MUV, CBCS, MSKCC, GOG, OSU CCG, UTBCS, GC-HBOC, HCSC, HEBCS, INHERIT BRCAs. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: Results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res & Treatm 2009 (in press).
Tavtigian SV, Oefner PJ, Babikyan D, Hatmann A, Healey S, Le Calvez-Kelm F, Lesueur F, Byrnes GB, Chuang S-C, Forey N, Feuchtinger C, Gioia L, Hall J, Hashibe M, Herte B, McKay-Chopin S, Thomes A, Vallee MP, Voegele C, Webb PM, Whiteman DC, Australian Cancer Study, BCFR, kConFab, Sangrajrang S, Hopper JL, Southey MC, Andrulis IL, John EM, Chenevix-Trench G. Rare evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet 2009;85(4):427-46.
McClure LA, Glaser SL, Shema SJ, Allen L, Quesenberry C, John EM, Gomez SL. Availability and accuracy of medical record information on language usage by multi-ethnic cancer patients. Journal of Immigrant and Minority Health 2009 Aug 15. [Epub ahead of print]
Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, Ozcelik H, Glendon G, Gerdes AM, Thomassen M, Sunde L, Caligo MA, Laitman Y, Kontorovich T, Cohen S, Kaufman B, Dagan E, Baruch RG, Friedman E, Harbst K, Barbany-Bustinza G, Rantala J, Ehrencrona H, Karlsson P, Domchek SM, Nathanson KL, Osorio A, Blanco I, Lasa A, Benítez J, Hamann U, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE, Peock S, Cook M, Frost D, Oliver C, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Cole T, Hodgson S, Godwin AK, Stoppa-Lyonnet D, Buecher B, Léoné M, Bressac-de Paillerets B, Remenieras A, Caron O, Lenoir GM, Sevenet N, Longy M, Ferrer SF, Prieur F, Goldgar D, Miron A, John EM, Buys SS, Daly MB, Hopper JL, Terry MB, Yassin Y, Singer CF, Gschwantler-Kaulich D, Staudigl C, Hansen TV, Barkardottir RB, Kirchhoff T, Pal P, Kosarin K, Offit K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deißler H, Fiebig B, Suttner C, Schönbuchner I, Gadzicki D, Caldes T, de la Hoya M, Pooley KA, Easton DF "Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers." Hum Mol Genet 2009;18(22):4442-56.
Nguyen-Dumont T, Le Calvez-Kelm F, Forey N, McKay-Chopin S, Garritao S, Gioia-Patricola L, De Silva D, Weigel R, BCFR, kConFab, Sangrajrang S, Lesueur F, Tavtigian SV. Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis. Hum Mutation 2009;30(6):884-890.
Fejerman L, Haiman CA, Reich D, Tandon A, Deo RC, John EM, Ingles SA, Ambrosone CB, Howard Bovbjerg D, Jandorf LH, Davis W, Ciupak G, Whittemore AS, Press MF, Ursin G, Bernstein L, Huntsman S, Henderson BE, Ziv E, Freedman ML. An admixture scan in 1,484 African American women with breast cancer. Cancer Epidemiol Biomarkers Prev 2009;18(11):3110-7.
Eeles RA *, Kote-Jarai Z *, Amin Al Olama A *, Giles GG *, Guy M *, Severi G *, Muir K *, Hopper JL *, Henderson BE *, Haiman CA *, Schleutker J *, Hamdy FC *, Neal DE *, Donovan JL *, Stanford JL *, Ostrander EA *, Ingles SA *, John EM *, Thibodeau SN *, Schaid D *, Park JY *, Spurdle A *, Clements J *, Dickinson JL *, Maier C *, Vogel W *, Dörk T *, Rebbeck TR *, Cooney KA *, Cannon-Albright L *, Chappuis PO *, Hutter P *, Zeegers M *, Kaneva R *, Zhang H-W *, Lu Y-J *, Foulkes WD *, English DR *, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O’Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu J-F, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, FitzGerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UK ProtecT Study Collaborators, The PRACTICAL Consortium, Douglas F. Easton. Identification of seven novel prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics 2009;41(10):1116-21. ( * joint authorship)
Kurian AW, McClure LA, John EM, Horn-Ross PL, Ford JM, Clarke CA. Second primary breast cancer occurrence according to hormone receptor status: A population-based study. J Natl Cancer Inst 2009;101(15):1058-65.
Cheng I, Witte JS, John EM, Cockburn MG, Clarke CA. Socioeconomic status and prostate cancer incidence and mortality among the diverse population of California. Cancer Causes Control 2009; June 13 [Epub ahead of print].
Phillips K-A, Milne RL, West DW, Goodwin PJ, Giles GG, Chang ET, Figueiredo JC, Friedlander ML, Keegan THM, Glendon G, Apicella C, O’Malley FP, Southey MC, Andrulis IL, John EM, Hopper JL. Pre-diagnosis reproductive factors and all-cause mortality for women with breast cancer in the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2009;18(6):1792-7.
Cheng C-Y, Kao WHL, Patterson B, Tandon A, Haiman CA, Harris TB, Xing C, John EM, Ambrosone CB, Brancati FL, Coresh J, Press MF, Parekh RS, Klag MJ, Meoni LA, Hsueh W-C, Fejerman L, Pawlikowska L, Freedman ML, Jandorf LH, Bandera EV, Ciupak GL, Nalls MA, Akylbekova EL, Orwoll ES, Leak TS, Miljkovic I, Li R, Ursin G, Bernstein L, Ardlie K, Taylor HA, Boerwinckle E, Zmuda JM, Henderson BE, Wilson JG, Reich D. Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet 2009;5(5):e1000490.
Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps AI, West DW, Whittemore AS. Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: Findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2009;18(4):1084-91.
Kibriya MG, Jasmine F, Argos M, Andrulis IL, John EM, Chang-Claude J, Ahsan H. A pilot genome-wide association study of early-onset breast cancer. Breast Cancer Res & Treatment 2009;114(3):463-77.
Rebbeck TR, Antoniou AC, Llopis TC, Nevanlinna H, Aittomaki K, Simard J, Spurdle AB, KConFab, Couch FJ, Pereira LH, Greene MH, Andrulis IL, Ontario Cancer Genetics Network, Pasche B, Kaklamani V, Breast Cancer Family Registry, Hamann U, Szabo C, Peock S, Cook M, Harrington PA, Dondaldson A, Male AM, Gardiner CA, Gregory H, Side LE, Robinson AC, Emmerson L, Ellis I, EMBRACE, Peyrat JP, Fournier J, Vennin P, Adenis C, Muller D, Fricker JP, Longy M, Sinilnikova OM, Stoppa-Lyonnet D, GEMO, Schmutzler RK, Versmold B, Engel C, Meindle A, Kast K, Schaefer D, Froster UG, Chenevix-Trench G, Easton DF. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Res Treat 2009; 115(1)185-92. Epub 2008 Jun 4.
Chang ET, Milne RL, Phillips KA, Figueiredo JC, Sangaramoorthy M, Keegan THM, Andrulis IL, Hopper JL, Goodwin PJ, O’Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, Whittemore, AS, West DW, John EM. Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry. Breast Cancer Res & Treatm 2009;117(1):167-76.
Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, Iriondo-Perez J, Miron A, Santella RM, Whittemore AS, Andrulis IL, Buys SS, Daly MB, Hopper JL, Seminara D, Senie RT, Terry MB, for the Breast Cancer Family Registry. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res & Treatm 2009;116(2):379-86.
Jasmine F, Ahsan H, Andrulis IL, John EM, Chang-Claude J, Kibriya MG. Whole-genome amplification enables accurate genotyping for microarray-based high-density single nucleotide polymorphism array. Cancer Epidemiol Biomarkers Prev 2008;17(12):3499-508.
Fejerman L, John EM, Huntsman S, Beckman K, Choudhry S, Perez-Stable E, González Burchard E, Ziv E. Genetic ancestry and risk of breast cancer among US Latinas. Cancer Res 2008;68(23)9723-8.
Wang J, John EM, Ingles SA. Five-lipoxygenase and 5-lipoxygenase activating protein gene polymorphisms, dietary linoleic acid, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17(10):2748-54.
Kote-Jarai Z, Easton D, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D, Cox A, Maier C, Vogel W, Guy M, Muir K, Lophatananon A, Kedda MA, Spurdle A, Steginga S, John EM, Giles G, Hopper J, Chappuis PO, Hutter P, Foulkes WD, Hamel N, Salinas CA, Koopmeiners JS, Karyadi DM, Johanneson B, Wahlfors T, Tammela TL, Stern MC, Corral R, McDonnell SK, Schürmann P, Meyer A, Kuefer R, Leongamornlert D, Tymrakiewitz M, Liu J, O’Mara T, Gardiner RA, Aitken J, Joshi AD, Severi G, English DR, Southey M, Al Olama AA, The PRACTICAL group, Eeles RA. Confirmation of prostate cancer susceptibility loci on chromosomes 3, 6, 7, 10, 11, 19 and X by an International Consortium, The PRACTICAL Study. Cancer Epidemiol Biomarkers Prev 2008; 17(8):2052–61.
Wang J, John EM, Horn-Ross PL, Ingles SA. Dietary fat, cooking fat, and breast cancer risk in a multiethnic population. Nutr Cancer 2008;60(4):492-504.
Setiawan VW, Chu L-H, John EM, Ding YC, Ingles SA, Bernstein L, Press M, Ursin G, Haiman C, Neuhausen SL. Mitochondrial DNA G10398A variant is not associated with breast cancer in African- American women. Cancer Genetics Cytogenetics 2008;181(1):16-9.
Garner CP, Diny YC, John EM, Ingles SA, Olopade OF, Huo D, Adebamowo C, Ogundiran T, Neuhausen SL. Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer risk in populations of African descent. Hum Genet 2008;123(3):247-55.
John EM, Miron A, Gong G, Phipps AI, Felberg I, Li FP, West DW, Whittemore AS. Prevalence of pathogenic BRCA1 mutation carriers in five US racial/ethnic groups. JAMA 2007;298(24):2869-76.
Breast Cancer Family Registry; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (Australasia); Ontario Cancer Genetics Network (Canada). Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast Cancer Res Treat 2008;109(1):67-75.
John EM, Schwartz GG, Koo J, Wang W, Ingles SA. Sun exposure, polymorphisms in the vitamin D receptor gene and breast cancer risk. Am J Epidemiol 2007;166(12):1409-19.
Keegan THM, Chang ET, John EM, Horn-Ross PL, Wrensch MR, Glaser SL, Clarke CA. Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area women: 1988-2004. Breast Cancer Res 2007;9(5):R62.
Apicella C, Dowty JG, Dite GS, Jenkins MA, Senie R, Daly MB, Andrulis IL, John EM, Buys SS, Li FP, Glendon G, Chung W, Ozcelik H, Miron A, Kotar K, Southey MC, Foulkes W, Hopper JL. Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women. Clin Genet 2007;72:87-97.
John EM, Koo J, Schwartz GG. Sun exposure and prostate cancer risk: Evidence for a protective effect of early life exposure. Cancer Epidemiol Biomarkers Prev 2007;16:1283-1286.
Hong AL, Huo D, Kim HJ, Chen YS, Niu Q, Cummings SA, John EM, West DW, Whittemore AS, Das S, Olopade OI. UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women. Drug Metab Disposition 2007;35(8):1254-61.
Haiman CA, Setiawan VW, Xia LY, Le Marchand L, Ingles SA, Giske Ursin G, Press M, Bernstein L, John EM, Henderson BE. A Variant in the Cytochrome P450 Oxidoreductase (POR) Gene is Associated with Breast Cancer Risk in African Americans. Cancer Res 2007;67(8):3565-8.
Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007;39(5):638-44.
John EM, Phipps AI, Knight JA, Milne RL, Dite GS, Hopper JL, Andrulis IL, Southey M, Giles GG, West DW, Whittemore AS, for the Breast Cancer Family Registry. Medical radiation exposure and breast cancer risk: Findings from the Breast Cancer Family Registry. Int J Cancer 2007;121(2):386-94.
Terry MB, Knight JA, Zablotska L, Wang Q, John EM, Daly M, Ozcelik H, Briollais L, Santella RM. Alcohol metabolism, alcohol intake, and Breast Cancer Risk: A sister-pair analysis. Breast Cancer Res & Treatm 2007;106(2):281-8.
Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles G, Godwin AK, Hisbshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, Southey MC, West DW, Whittemore AS, Wu H, Andrulis IL, O’Malley FP, for the Breast Cancer Family Registry. BRCA2 Mutation-Associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles from Tissue Microarrays. Am J Surg Pathol 2007;31(1):121-128.
Ziv E, John EM, Choudhry S, Koh J, Lorizio W, Perez-Stable E, Burchard EG. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev 2006;15(10):1878-1885.
Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MRE, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, kConFab Investigators, Ontario Cancer Genetics Network Investigators, Whittemore AS. BRCA1 and BRCA2 mutation carriers, oral contraceptive use and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev 2006;15(10):1863-1870.
Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer A, Whittemore AS, West DW, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P. Population-based estimates of breast cancer risks associated with ATM variants 7271T>G and IVS10-6T>G from the Breast Cancer Family Registry. Human Mut 2006;27(11):1122-28.
Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African American men. Proc Natl Acad Sci USA 2006;103(38):14068-73.
McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, kConFab Investigators, Southey M, West DW, Hopper KL, Whittemore AS. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations under age 50 years. Cancer Epidemiol Biomarkers Prev 2006;15(8):1565-7.
Liu X-Q, Paterson AD, John EM, Knight JA. The role of self-defined race/ethnicity in population stratification control. Annals Hum Genetics 2006;70(Pt 4):496-505.
Lee JS, John EM, McGuire V, Felberg A, Ostrow KL, DiCioccio RA, Li FP, Miron A, West DW, Whittemore AS. Breast and ovarian cancer in relatives of cancer patients with and without BRCA mutations. Cancer Epidemiol Biomarkers Prev 2006;15(2):359-63.
Bernstein JL, Teroka SN, John EM, Andrulis IL, Knight JA, Lapinkski R, Olson ER, Wolitzer AL, Seminara D, Whittemore AS, Concannon P. The CHEK2*1100delC allelic variant and risk of breast cancer: Screening results from the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2006;15(2):348-52.
Spurdle AB, Antoniou AC, Duffy D, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey M, Godwin A, Beck J, Miron A, Daly M, Santella R, Hopper J, John EM, Andrulis I, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G, Australian Breast Cancer Family Study, Australian Jewish Breast Cancer Study, Breast Cancer Family Registry, Interdisciplinary Health Research International Team on Breast Cancer Susceptibility, The Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, and Epidemiological Study of Familial Breast Cancer Study Collaborators. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2006;15(1):76-9.
Wang W, John EM, Ingles SA. Androgen receptor and prostate-specific antigen gene polymorphisms and breast cancer in African-American women. Cancer Epidemiol Biomarkers Prev 2005;14(12):2990-4.
John EM, Phipps AI, Davis A, Koo J. Migration history, acculturation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14(12):2905-13.
Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJQ, Giles GG, Ziogas A, Andrulis IL, Whittemore AS, Hopper JL for the Breast Cancer Family Registry. Inverse association between ovarian cysts and breast cancer in the Breast Cancer Family Registry. Int J Cancer 2006;118(1):197-202.
John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles S. Sun exposure, vitamin D receptor polymorphisms and risk of advanced prostate cancer. Cancer Res 2005;65(12):5470-9.
Robinson WR, Stevens J, Gammon MD, John EM. Obesity before age 30 and risk of advanced prostate cancer. Am J Epidemiol 2005;161(12):1107-14.
Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Southey MC, Giles GG, McCredie MRE, Hopper HL, and Whittemore AS, for the Breast Cancer Family Registry. Oral contraceptive use and risk of early-onset breast cancer in carriers and non-carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2005;14(2):350-56.
Whittemore AS, Balise RR, Pharoah PDP, DiCioccio RA, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)4, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BAJ, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS. Oral Contraceptive Use and Ovarian Cancer Risk among Carriers of BRCA1 or BRCA2 Mutations. Br J Cancer 2004;91(11):1911-5.
Whittemore AS, Gong Gail, John EM, McGuire V, LI F, Ostrow K, DiCioccio R, Felberg A, West D. Prevalence of BRCA1 mutation carriers among US non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev 2004;13(12):2078-83.
McGuire V, Felberg A, Mills M, Ostrow KL, DiCioccio R, John EM, West DW, Whittemore AS. Contraceptive and reproductive history in relation to ovarian cancer risk in carriers and noncarriers of BRCA1 mutations. Am J Epidemiol 2004;160(7):613-18.
John EM, Dreon DM, Koo J, Schwartz GG. Residential sunlight exposure is associated with a decreased risk of prostate cancer. J Steroid Biochem Mol Biol 2004;89-90(1-5):549-52.
John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O’Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D, for the Breast Cancer Family Registry. The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Research 2004; 6:R375-R389.
John EM, Horn-Ross PL, Koo J. Lifetime physical activity and breast cancer risk in a multiethnic population: The San Francisco Bay Area Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2003;12(11 Pt 1):1143-52.
Horn-Ross PL, John EM, Canchola AJ, Lee M, Stewart SL. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003;95(15):1158-64. Erratum in J Natl Cancer Inst 2006;98(20):1501.
Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West WW, Felberg A, Whittemore AS. Segregation analysis of prostate cancer in families of young white, African-American and AsianAmerican men. Cancer Causes and Control 2002;13(5):471-82.
Horn-Ross PL, John EM, Lee M, Stewart SL, Koo J, Sakoda LC, Shiau AC, Goldstein J, Davis P, Perez-Stable EJ. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 2001;154(5):434-441.
Beck JC, Beiswanger CM, John EM, Satariano E, West D. Successful transformation of cryopreserved lymphocytes: A resource for epidemiological studies. Cancer Epidemiol Biomarkers Prev 2001;10(5):551-54.
Wu AH, Whittemore AS, Kolonel LN, Stanzyk FZ, John EM, Gallagher RP, West DW. Lifestyle determinants of 5α-reductase metabolites in older African-American, white and Asian-American men. Cancer Epidemiol Biomarkers Prev 2001;10(5):533-38.
Kolonel LM, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS, Jr. Vegetables, fruits, legumes and prostate cancers: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 2000;9(8):795-804.
Horn-Ross PL, Lee M, John EM, Koo J. Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control 2000;11(4):299-302.
Horn-Ross PL, Barnes S, Lee M, Coward L, Mandel JE, Koo J, John EM, Smith M. Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control 2000;11(4):289-98.
John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: The NHANES I Epidemiologic Follow-up Study, 1971-1975 to 1992. Cancer Epidemiol Biomarkers Prev 1999; 8(5):399-406.
Gammon MD, John EM, Britton JA. Recreational and occupational physical activity and the risk of breast cancer. J Natl Cancer Inst 1998;90(2):100-17.
Shibata A, Whittemore AS, Imai K, Kolonel LN, Wu AH, John EM, Stamey TA, Paffenbarger RS. Serum levels of prostate-specific antigen among Japanese-American men and men in Japan. J Natl Cancer Inst 1997;89(22):1716-20.
Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, Dreon DM, Paffenbarger RS, Jr. Serum androgens in relation to lifestyle factors in older African-American, white, and Asian men in the U.S. and Canada. Cancer Epidemiol Biomarkers Prev 1995;4(7):735-41.
Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, Teh C-Z, Paffenbarger RS, Jr. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87(9):652-61.
John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, West DW, Hankin J, Dreon DM, Teh C-Z, Burch JD, Paffenbarger RS, Jr. Vasectomy and prostate cancer: Results from a multi-ethnic case-control study. J Natl Cancer Inst 1995;87(9):662-69.
Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, The CZ, Stamey T. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995;141(8):732-40.
John EM, Savitz DA. Effect of a monetary incentive on response to a mail survey. Ann Epidemiol 1994;4(3):231-35.
John EM, Savitz DA, Shy CM. Spontaneous abortions among cosmetologists. Epidemiology 1994;5(2):147-55.
Kelsey JL, John EM. Lactation and risk for breast cancer. (Editorial). N Engl J Med 1994;330(2):136-37.
John EM, Whittemore AS, Harris R, Itnyre J, and the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in Black women. J Natl Cancer Inst 1993;85(2):142-47.
Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15(1):36-47.
Gammon MD, John EM. Recent etiologic hypotheses concerning breast cancer. Epidemiol Rev 1993;15(1):163-68.
John EM, Kelsey JL. Radiation and other environmental exposures and breast cancer. Epidemiol Rev 1993;15(1):157-62.
Dreon DM, John EM, DiCiccio Y, Whittemore AS. Use of NHANES data to assign nutrient densities to food groups in a multi-ethnic diet history questionnaire. Nutr Cancer 1993;20(3):223-30.
Savitz DA, Zhang J, Schwingl P, John EM. Association of paternal alcohol use with gestational age and birth weight. Teratology 1993;46(5):465-71.
Feingold L, Savitz DA, John EM. Use of a job-exposure matrix to evaluate parental occupations and childhood cancer. Cancer Causes Control 1992;3(2):161-69.
John EM, Savitz DA, Sandler DP. Prenatal exposure to parents' smoking and childhood cancer. Am J Epidemiol 1991;133(2):123-132.
Savitz DA, John EM, Kleckner RC. Magnetic field exposure from electric appliances and childhood cancer. Am J Epidemiol 1990;131(5):763-73.
Savitz DA, Wachtel H, Barnes FA, John EM, Tvrdik JG. Case-control study of childhood cancer and exposure to 60-hz magnetic fields. Am J Epidemiol 1988;128(1):21-38.
John EM, Curtis P. Physicians' attitude to after-hours callers: A five year study in a university-based family practice center. Int J Fam Pract 1988;5:168-173.
Wing S, Hayes C, Heiss G, John E, Knowles M, Riggan W, Tyroler HA. Geographic variation in the onset of decline of ischemic heart disease mortality in the United States. Am J Pub Hlth 1986;76(12):1404-08.
Back to Esther John's profile
|
